Form D · Biotechnology

Erytech Pharma S.A.

Lyon, I0 · CIK 0001624422

Offering snapshot reported Dec 22, 2015 · SEC filing

Reported sold
$3.95M
Offering amount: $3.95M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 7, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 22, 2015Initial$3,954,924No comparison7SEC filing
Nov 10, 2014Amendment$37,232,686$0vs Nov 7, 201433SEC filing
Nov 7, 2014Initial$37,232,686No comparison33SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$277K
Finders' fees
$0
Form D file number
021-253608

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Jefferies LLC2347
Leerink Partners39011
LifeSci Capital LLC168404
Bryan, Garnier & Co. Ltd.None

Source: Form D, filed Dec 22, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sven Andreasson Director
Philippe Archinard Director
Jerome Bailly Executive
J?R?Me Bailly Director
Gil Beyen Director, Executive
None Bryan Garnier & Co Promoter
Luc Dochez Director
None Galenos Director
Martine George Director
Yann Godfrin Director, Executive
Pierre Olivier Goineau Director, Executive, Promoter
None Life Sci Capital Promoter
Eric Soyer Executive
Hilde Windels Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
60 Avenue Rockefeller
Lyon, I0, 69008